MENU
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.94M
P/E Ratio
N/A
Total Cash
53.08M
Projected Growth
N/A
Total Debt
14.76M
Revenue
566K
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
0.75
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
OVID
Capitalization
23.9M
P/E Ratio
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
53.1M
Total Cash/Share
0.75
Total Debt
14.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
566K
ROE
N/A
Book Value
68.2M
P/B Ratio
0.35
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
71K
Current Ratio
5.32
Current Revenue Per Employee
3304.35
Dividends Per Share - Security
N/A
EBITDA
-61.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-22.38
Shares Held By Institutions
49.2M
Shares Outstanding - Current
71.1M
Total Liabilities
23.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-65.192
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Provides medicines to children and adults with neurological disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com